# A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)

> **NCT00652769** · PHASE3 · COMPLETED · sponsor: **University College London Hospitals** · enrollment: 168 (estimated)

## Conditions studied

- Bronchogenic Carcinoma

## Interventions

- **PROCEDURE:** Endobronchial or Endoscopic Ultrasound
- **PROCEDURE:** Bronchoscopy, CT-guided biopsy, PET scan, Mediastinoscopy

## Key facts

- **NCT ID:** NCT00652769
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-09
- **Final completion:** 2012-07
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2017-11-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652769, "A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00652769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*